iSpecimen (ISPC) EBIAT (2020 - 2025)
iSpecimen (ISPC) has 6 years of EBIAT data on record, last reported at -$2.8 million in Q3 2025.
- For Q3 2025, EBIAT fell 93.12% year-over-year to -$2.8 million; the TTM value through Sep 2025 reached -$11.5 million, down 21.1%, while the annual FY2024 figure was -$12.5 million, 12.6% down from the prior year.
- EBIAT reached -$2.8 million in Q3 2025 per ISPC's latest filing, down from -$1.0 million in the prior quarter.
- Across five years, EBIAT topped out at -$1.0 million in Q2 2025 and bottomed at -$6.0 million in Q4 2024.
- Average EBIAT over 5 years is -$2.5 million, with a median of -$2.4 million recorded in 2022.
- Peak YoY movement for EBIAT: tumbled 701.25% in 2021, then soared 50.34% in 2025.
- A 5-year view of EBIAT shows it stood at -$2.1 million in 2021, then fell by 5.33% to -$2.2 million in 2022, then tumbled by 42.29% to -$3.1 million in 2023, then plummeted by 96.77% to -$6.0 million in 2024, then surged by 54.01% to -$2.8 million in 2025.
- Per Business Quant database, its latest 3 readings for EBIAT were -$2.8 million in Q3 2025, -$1.0 million in Q2 2025, and -$1.7 million in Q1 2025.